In previous studies, the hypermethylation of the ptpn6 promoter was observed in leukemia and lymphoma14,68–70, esophageal squamous cell carcinoma71, gastric adenocarcinoma72, breast cancer73, endometrial carcinoma54, and nasopharyngeal carcinoma74. Here, PTPN6 is linked to leukemia.